Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): A prospective methylphenidate-controlled trial

Journal of Child Neurology

Volumn 27, Issue 12, 2012, Pages 1547-1552

  Goez, Helly R ^a   Scott, Ori ^a   Nevo, Neta ^b   Bennett Back, Odeya ^b   Zelnik, Nathanel ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CARMEL MEDICAL CENTER   (Israel)

Author keywords

ADHD; attention deficit hyperactivity disorder; methylphenidate; modafinil; Test of Variables of Attention

Indexed keywords

METHYLPHENIDATE; MODAFINIL;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; HUMAN; INSOMNIA; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; SINGLE DRUG DOSE; TASK PERFORMANCE; TEST OF VARIABLES OF ATTENTION;

ADOLESCENT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BENZHYDRYL COMPOUNDS; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84868023839     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073812439101     Document Type: Article

References (22)

1. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005 ; 366 (9481). 237-248 (Pubitemid 40981053)
2. Tripp G, Wickens JR. Neurobiology of ADHD. Neuropharmacology. 2009 ; 57 (7-8). 579-589
3. Brown RT, Amler RW, Freeman WS, et al. Treatment of attention deficit/hyperactivity disorder: overview of the evidence. Pediatrics. 2005 ; 115 (6). e749 - e757
4. Scahill L, Carroll D, Burke K. Methylphenidate: mechanism of action and clinical update. J Child Adolesc Psychiatr Nurs. 2004 ; 17 (2). 85-86
5. Schwitzer JB, Holocomb HH. Drugs under investigation for attention-deficit hyperactivity disorder. Curr Opin Investig Drugs. 2002 ; 3: 1207-1211
6. Rugino T. A review of modafinil film-coated tablets for attention deficit/hyperactivity disorder in children and adolescents. Neuropsychiatr Dis Treat. 2007 ; 3 (3). 293-301 (Pubitemid 47215007)
7. Ferarro L, Antonelli T, O'Connor WT, et al. Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers. Biol Psychiatry. 1997 ; 42 (12). 1181-1183 (Pubitemid 28049931)
8. Ballon JS, Feifel D. A systematic review of modafinil: potential clinical use and mechanisms of action. J Clin Psychiatry. 2006 ; 67 (4). 554-566 (Pubitemid 43764232)
9. Swanson JM, Greenhill LL, Lopez FA, et al. Modafinil film-coated tablets in children and adolescent with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J Clin Psychiatry. 2006 ; 67 (1). 137-147 (Pubitemid 43213294)
10. Biederman J, Swanson JM, Wigal SB, et al. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible dose study. Pediatrics. 2005 ; 116 (6). e777 - e784
11. Greenhill LL, Biederman J, Boellner SW, et al. A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006 ; 45 (5). 503-511
12. Amiri S, Mohammadi MR, Mohammadi M, et al. Modafinil a treatment for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized clinical trial. Prog Neuropsychopharmacol Biol Psychiatry. 2008 ; 1:32 (1). 145-149
13. Greenberg LM, Waldman ID. Developmental normative data on the Test of Variables of Attention (TOVATM). J Child Psychol Psychiatry. 1993 ; 34: 1019-1930
14. Forbes GB. Clinical utility of the Test of Variables of Attention (TOVA), in the diagnosis of attention-deficit/hyperactivity disorders. J Clin Psychol. 1998 ; 54: 461-476 (Pubitemid 28235317)
15. Diagnostic and Statistical Manual of Mental Diseases. 4 th ed. Washington, DC: American Psychiatric Publishing; 1994. Washington, DC: American Psychiatric Publishing ; 1994 :
16. Forbes GB. Clinical utility of the Test of Variables of Attention (TOVA), in the diagnosis of attention-deficit/hyperactivity disorders. J Clin Psychol. 1998 ; 54 (4). 461-476 (Pubitemid 28235317)
17. Manor I, Meidad S, Zalsman G, et al. Objective versus subjective assessment of methylphenidate response. Child Psychiatry Hum Dev. 2008 ; 39: 273-282
18. Reddy LA, Newman E, Pedigo TK, et al. Concurrent validity of the pediatric attention disorders diagnostic screener for children with ADHD. Child Neuropsychol. 2010 ; 16: 478-493
19. Llorente AM, Voigt R, Jensen CL, et al. The Test of Variable of Attention (TOVA): internal consistency (Q(1) vs. Q(2) and Q(3) vs. Q(4)) in children with attention deficit/hyperactivity disorder (ADHD). Child Neuropsychol. 2008 ; 14: 314-322 (Pubitemid 351892635)
20. Rugino TA, Copley TC. Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. J Am Acad Child Adolesc Psychiatry. 2001 ; 40 (2). 230-235 (Pubitemid 32111027)
21. Rugino TA, Samsock TA. Modafinil in children with attention-deficit hyperactivity disorder. Pediatr Neurol. 2003 ; 29 (2). 136-142 (Pubitemid 37324386)
22. Frazer, PA Cephalon, Inc: ; 2006 :